Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance

New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today (Wednesday) between Cancer Research UK, LifeArc and Ono Pharmaceutical Co., Ltd.

Alliance enables clinical trial of experimental treatment for epidermolysis bullosa

An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to start trials in patients thanks to the perseverance of the charity team at LifeArc.

Melanie Lee, a life in life sciences

Melanie Lee, LifeArc CEO, reflects on a career in life sciences leading to her win of the BIA Lifetime Achievement Award in 2019.